Orion Market Research Report Cardiac Biomarker Market | Page 2

Recently, Orion Market Research (OMR) published a market research report on the Global Cardiac
Biomarker Market. The Global Cardiac Biomarkers Market is anticipated to grow at a CAGR of 7.1% by
2023. According to the World Health Organization, in 2015, around 17.7 million of people died due to
cardiovascular diseases and out of these 7.4 million were affected due to coronary heart diseases and an
approximately 6.7 million dues to heat stroke. Cardiac biomarkers are utilized to detect and measure the
risk factor associated with heart diseases. The cardiac biomarkers have been successfully tested to provide
a more accurate prediction of heart failure after chest pain compared to more conventional methods. This
is a major factor which may fuel the growth of the market. The market is also affected by the technological
development of cardiac biomarker.
Browse the full report of “Cardiac Biomarker Market, by Type (Creatine Kinase, Troponins, Myoglobin,
Natriuretic Peptides, Ischemia Modified Albumin, Others), by Application (Myocardial Infraction, Congestive
Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Others), by Location of Testing (Laboratory Testing,
Point of Care Testing) – Global Trends, Market Size, Share, Growth, Research and Forecast 2018-2023” at
https://www.omrglobal.com/industry-reports/cardiac-biomarkers-market/
Furthermore, the global cardiac biomarker market is segmented on the basis of type, application, and
location of testing. The report provides detailed & insightful chapters which include market overview, key
findings, strategic recommendations, market estimations, market determinants, key company analysis,
market insights, company profiling, market segmentation, geographical analysis, analyst insights and
predictive analysis of the market.
Market Segmentation
1. Cardiac Biomarker Market by Type
• Creatine Kinase(ck-mb)
• Troponins(t,i)
• Myoglobin
• Natriuretic Peptides (bnp & nt-probnp)
• Ischemia Modified Albumin
• Others
2. Cardiac Biomarker Market by Application
• Myocardial Infraction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Atherosclerosis
• Others